Candel Therapeutics Inc. has appointed Charles Schoch as Chief Financial Officer, transitioning from his role as interim CFO, effective immediately. Schoch has been with Candel since November 2021 and has held various financial positions, most recently as VP of Finance and Corporate Controller. As interim CFO, he led the company through significant financial milestones, including a capital raise of approximately $86 million.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Candel Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9482469-en) on June 23, 2025, and is solely responsible for the information contained therein.